Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.

Meng-Hsuan HsiehMing-Jong BairPei-Chien TsaiKuo-Chih TsengChing-Chu LoChi-Yi ChenHsing-Tao KuoChao-Hung HungHsueh-Chou LaiCheng-Yuan PengJing-Houng WangJyh-Jou ChenPei-Lun LeeRong-Nan ChienChi-Chieh YangGin-Ho LoJia-Horng Kao Chun-Jen LiuChen-Hua LiuSheng-Lei YanChun-Yen LinWei-Wen SuCheng-Hsin ChuChih-Jen ChenShui-Yi TungChi-Ming TaiChih-Wen Lin Pin-Nan ChengYen-Cheng ChiuChia-Chi WangJin-Shiung ChengWei-Lun TsaiHan-Chieh LinYi-Hsiang HuangMing-Lun YehChung-Feng HuangJee-Fu HuangChia-Yen DaiMing-Lung YuWan-Long Chuangnull null

Published in: Journal of gastroenterology and hepatology (2021)

Diabetes and baseline impaired renal function were strongly associated with progression to ESRD with maintenance dialysis among chronic HCV-infected patients after antiviral therapy.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
type diabetes
cardiovascular disease
hepatitis c virus
newly diagnosed
prognostic factors
human immunodeficiency virus
glycemic control
mesenchymal stem cells
cell therapy
patient reported